Sequoia Capital
China Nuokang sees low US IPO
Sequoia Capital China investee China Nuokang Bio-Pharmaceutical Inc. fell over 11.1% before closing some 3.7% down on its first day of trading on the US NASDAQ.
Sina taps CITIC, FountainVest, Sequoia for $180 million
Sequoia Capital, FountainVest Partners and CITIC Capital Holdings have reportedly agreed to finance leading PRC web portal Sina in a $180 million management buy-in to reinforce the positions of CEO Charles Chao and other senior executives.
